Abstract

The liver is a primary hub for space-occupying lesions (SOL), detected through advanced imaging technologies. While benign liver lesions often require no immediate intervention, the rising prevalence of hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) demands thorough evaluation. Understanding clinical, biological, and radiological aspects of liver lesions is crucial. Comparatively, splenic lesions, less common than in other organs, range from asymptomatic to critical cases. Advanced imaging and surgical technologies enhance identification, yet a universal protocol for splenic lesions is lacking. Our study explores the varied etiologies, symptomatology, and distinctive management strategies for SOL in the liver and spleen, proposing a tailored algorithm based on current literature.

Description